South Korea's Disgraced Scientist Goes Into Pet-Cloning Business
By Associated Press,
Associated Press
| 05. 14. 2008
SEOUL, South Korea — Disgraced South Korean stem cell scientist Hwang Woo-suk has set up a bio-technology firm specializing in cloning pet animals, a scientist close to Hwang said Wednesday.
Hwang, whose breakthrough human cloning research was later proved to be faked, recently established a new research firm in Seoul, said Park Se-pill, a Cheju National University professor and well-known stem cell scientist. Park said he spoke with Hwang a few days ago.
"He told me that he needs foreign capital to continue his research, but it's difficult to get it unless he sets up a new research institute and becomes its head," Park said.
Last month, the Korean Customs Service unveiled seven cloned Labrador retrievers being trained near Incheon International Airport, west of Seoul, to sniff out drugs and explosives.
The cloning work was conducted by a team of Seoul National University scientists who in 2005 successfully created the world's first known dog clone, an Afghan hound named "Snuppy."
The team is led by Professor Lee Byeong-chun, who was a key aide to Hwang.
South Korea's Yonhap News Agency...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...